Approx.280 pages - Discusses underlying cellular and molecular mechanisms altered in protein-associated neurodegenerative disorders - Describes methods for detection and analysis of protein aggregates - Features advancements in therapeutics and emerging techniques to treat these disorders - Covers implications in a variety of neurodegenerative diseases, including Alzheimer's, Parkinson's, ALS, Creutzfeldt-Jakob disease, Cystic fibrosis, Gaucher's disease, and Polyglutamine diseases, including Huntington's and other related proteinopathies